Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignancies

Title
Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignancies
Authors
Keywords
Antibody drug conjugate, Hematologic malignancies, Cytotoxic compounds, Pharmacology, DNA damaging agents, Non-Hodgkin's lymphoma
Journal
MOLECULAR IMMUNOLOGY
Volume 67, Issue 2, Pages 107-116
Publisher
Elsevier BV
Online
2014-10-09
DOI
10.1016/j.molimm.2014.09.014

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search